Pharma Journalist -

SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. …
Read More...

SMi Presents the 16th Annual Conference: Parallel Trade 2022 Conference Date: 21st – 22nd  March 2022 Workshop date: 23rd March 2022 Website:  www.parallel-trade.com/ Navigating…
Read More...

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted expedited approval of a supplemental new drug application (sNDA) for Veklury (remdesivir)…
Read More...

AbbVie announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), a systemic…
Read More...

MustGrow Biologics Corp. and Bayer have signed an Exclusive Agreement to evaluate MustGrow's biological technologies to determine efficacy and commercial potential in key agricultural…
Read More...

Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Apprentice.io, a leading provider of Intelligent Manufacturing Execution Systems (MES) designed…
Read More...

Nuvation Bio Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-868, a BD2-selective oral small…
Read More...

Senhwa Biosciences, Inc. a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that the US Food and Drug…
Read More...

Bristol-Myers Squibb K.K. announced that Japan’s Ministry of Health, Labour and Welfare has approved Abecma (idecabtagene vicleucel), a B-cell maturation antigen (BCMA)-directed…
Read More...

Syapse announced that Pfizer will continue working with Syapse to advance the use of real-world data (RWD) from the Syapse Learning Health Network (LHN), as an extension of the…
Read More...